Pursuant to the Regulation 30 of the SEBI Listing Regulations, Dr. Lal PathLabs has informed that it attached copies of newspaper advertisement of Financial Results of the Company for the quarter and half year ended on September 30, 2022, published in Financial Express and Jansatta on November 09, 2022.
The above information is a part of company’s filings submitted to BSE.